Free Trial
CVE:BRM

BioRem (BRM) Stock Price, News & Analysis

BioRem logo
C$2.05 -0.01 (-0.49%)
As of 09/3/2025 05:40 PM Eastern

About BioRem Stock (CVE:BRM)

Key Stats

Today's Range
C$2.05
C$2.09
50-Day Range
C$2.02
C$2.45
52-Week Range
C$1.67
C$3.45
Volume
14,733 shs
Average Volume
69,319 shs
Market Capitalization
C$33.05 million
P/E Ratio
12.58
Dividend Yield
6.47%
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive BRM Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for BioRem and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

BRM Stock News Headlines

Cormark Has Negative Estimate for BioRem FY2026 Earnings
Cormark Has Pessimistic View of BioRem FY2025 Earnings
50-yr Wall Street Legend Issues Mag 7 Warning
A massive money shift is underway in the AI market. And it's opening up an extraordinary opportunity in a NEW kind of AI stock.tc pixel
BRM:CA BioRem Inc.
See More Headlines

BRM Stock Analysis - Frequently Asked Questions

BioRem's stock was trading at C$3.05 at the start of the year. Since then, BRM shares have decreased by 32.8% and is now trading at C$2.05.

BioRem Inc. (CVE:BRM) posted its quarterly earnings results on Wednesday, November, 6th. The company reported $0.12 EPS for the quarter. BioRem had a net margin of 12.91% and a trailing twelve-month return on equity of 65.14%.

Shares of BRM stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.

Based on aggregate information from My MarketBeat watchlists, some other companies that BioRem investors own include TVA Group (TVA.B), Questor Technology (QST), AutoZone (AZO), Cadence Design Systems (CDNS), FormFactor (FORM), Intel (INTC) and K92 Mining Inc. (KNT.V) (KNT).

Company Calendar

Last Earnings
11/06/2024
Today
9/03/2025

Industry, Sector and Symbol

Stock Exchange
CVE
Industry
Pollution & Treatment Controls
Sub-Industry
Pharmaceutical Products
Current Symbol
CVE:BRM
CIK
N/A
Fax
N/A
Employees
34,300
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
C$0.16
Trailing P/E Ratio
12.58
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
C$5.40 million
Net Margins
12.91%
Pretax Margin
N/A
Return on Equity
65.14%
Return on Assets
14.61%

Debt

Debt-to-Equity Ratio
37.47
Current Ratio
1.91
Quick Ratio
1.08

Sales & Book Value

Annual Sales
C$38.36 million
Price / Sales
0.86
Cash Flow
C$0.55 per share
Price / Cash Flow
3.70
Book Value
C$0.63 per share
Price / Book
3.25

Miscellaneous

Outstanding Shares
16,120,000
Free Float
N/A
Market Cap
C$33.05 million
Optionable
Not Optionable
Beta
1.25
A Guide To High-Short-Interest Stocks Cover

MarketBeat's analysts have just released their top five short plays for September 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.

Get This Free Report

This page (CVE:BRM) was last updated on 9/4/2025 by MarketBeat.com Staff
From Our Partners